![[Avant Droite] Jambe de suspension pour 13-14 Hyundai Sonata 12.64](https://cdn.shopify.com/s/files/1/0642/1105/8866/files/KSS-106155-01.jpg?v=1771682276)
[Avant Droite] Jambe de suspension pour 13-14 Hyundai Sonata 12.64" Center To Length KSS-106155 2020-mercedes-benz-gls450 Numéro de pièce: KCW-100442 KDA-100498
EUR112.31EUR161.31
Pay in 4 interest-free payments of $28.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
Harbor notes
Description
[Avant Droite] Jambe de suspension pour 13 14 Hyundai Sonata 12.64" Center To Length KSS 106155 2020 mercedes benz gls450 Numéro de pièce: KCW 100442 KDA 100498 Numéro de pièce: KCW 100442 63067 SEE BR31346 53235 48880459 748880459 248880459 SEE 126335 780459 981036 BD126509E BD126509 DS1 53235 7741 8338 8402 9290 PF7741M PF7741X SS9290X SS7741X AD7741 QE7741X D866 866 xCMX D866 PR53036 AG53036 53036 2164579 YH145672C YH145672 120 Produit: Jambe de suspension Véhicules (consultez le tableau d'ajustement pour des informations détaillées sur le fitment):
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant Droite] Jambe de suspension pour 13-14 Hyundai Sonata 12.64" Center To Length KSS-106155 2020-mercedes-benz-gls450 Numéro de pièce: KCW-100442 KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.